Enliven Therapeutics
2026 Annual Meeting

View Documents

Investor Materials

Annual Report

View an enhanced version of the report summarizing our financial and
operational performance for the past year.

View Document

Proxy Statement

View the enhanced document outlining key information
about the upcoming shareholder meeting.

View Document

Request Paper Materials

Request paper copies of the above proxy materials online now, by email
or by phone by dialing 866-648-8133.

Request Online Request by Email

Voting

Your vote is important! Please be sure to vote your shares online now or by phone by dialing 866-305-2950.

Vote Now

Annual Meeting Details

Date:

June 9, 2026

Virtual Meeting:

Time:

10:00 a.m. Mountain Time

About Us

We are a biopharmaceutical company focused on discovering and developing small molecule kinase inhibitors to address existing and emerging unmet needs in oncology. With a precision oncology approach, our aim is to improve survival and enhance overall well-being for cancer patients.

Learn More

Enliven Therapeutics2026 Annual Meeting